
The word dependence can do too much work in a psychiatric encounter. It can describe an adaptation to medication, suggest an addiction diagnosis, and appear to justify a prescribing decision, all before anyone has explained which meaning they intend.
That ambiguity deserves attention. A clinician who writes that a patient is dependent on a benzodiazepine has not yet told the reader whether the concern is withdrawal, a pattern of problematic use, or both. Those questions belong in the assessment. They should not be answered by the same undefined word.
The 2025 joint benzodiazepine tapering guideline distinguishes physical dependence from a benzodiazepine use disorder. Its discussion of substance use disorder includes impaired control and continued use despite adverse consequences. Physical dependence alone does not establish that diagnosis.[1]
The distinction is useful precisely because it leaves more than one question open.
Separate the diagnosis from the prescribing decision
Consider two statements a psychiatrist might make: there is insufficient evidence to diagnose a use disorder, and the current prescription deserves reconsideration. Neither statement logically cancels the other.
The first concerns what the available history supports. The second concerns a treatment decision. Treating them as opposites creates an unnecessary argument about whether the patient belongs in one category before the medication can be discussed at all.
The FDA's class warning makes clear that physical dependence can occur during prescribed use. It also warns that abrupt stopping or overly rapid dose reduction can cause serious withdrawal, including life-threatening seizures.[2] Those risks do not wait for a diagnostic label to be settled.
Equally, explaining dependence should not become a promise that every existing prescription will continue unchanged. An explanation of what a term means is not a commitment to a particular treatment. The conversation can recognize the patient's experience while still examining whether the treatment fits their present circumstances.
That is a more honest starting point than making reassurance conditional on agreement about the refill.
Ask what the label is meant to explain
For editorial purposes, a useful way to examine a note is to ask what evidence would remain if the word dependent were removed. Is there a description of the person's medication use? Does the note identify the concern? Or does the label carry an argument that has never been written out?
This is not a diagnostic instrument. It is a test of whether the prose says what its author means.
If the concern is a possible use disorder, name the observed pattern and the uncertainty that still needs assessment. If the concern is a medication change, explain why that change is being considered. If several concerns coexist, give each enough space to be understood.
Precision also means resisting conclusions about motive. Disagreement with a proposed plan is an event in the conversation. Turning it into an explanation of the person's character adds a claim the disagreement itself cannot establish.
The patient should be able to hear a description of the clinical concern without having to decode whether a term is being used biologically, diagnostically, or as criticism.
A careful distinction still requires a plan
The joint guideline recommends ongoing assessment of the benefits and risks of continuing treatment and of tapering, with patient involvement. Most of its recommendations rely on clinical consensus because tapering evidence is limited. Its scope is adults taking benzodiazepines regularly who may be physically dependent; it is not a universal guide to initiating these medicines.[1]
The FDA calls for an individualized gradual reduction when reducing or discontinuing treatment, with monitoring and support, rather than one standard schedule for everyone.[2]
This article does not turn those principles into a dosing recipe. The narrower point is about the reasoning that precedes one. A use-disorder assessment and a medication decision each need their own explanation, even when they occur in the same appointment.
Words cannot replace that work. They can, however, make it easier to see when the work remains unfinished. Before writing dependence as the conclusion, spell out the question it is supposed to answer.
Sources
Brunner E, Chen CYA, Klein T, et al. Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits. Journal of General Internal Medicine. 2025;40:2814-2859. Published online June 17, 2025. Publisher full text; executive summary, scope, and Box 1.
FDA. FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. September 23, 2020. Official Drug Safety Communication; clinician and patient sections.
Educational Disclaimer: This article is for professional education and general information. It does not provide individualized medical advice, establish a diagnosis, or prescribe a medication or withdrawal schedule. Medication decisions require assessment by the treating clinician. Patients should not abruptly stop a benzodiazepine or change their dose without discussing a plan with their clinician.